6-Hydroxymelatonin converts Fe (III) to Fe (II) and reduces iron-induced lipid peroxidation

Life Sciences

Volumn 72, Issue 12, 2003, Pages 1367-1375

  Maharaj, Deepa S ^a   Limson, Janice L ^a   Daya, Santy ^a  

^a RHODES UNIVERSITY   (South Africa)

Author keywords

6 Hydroxymelatonin; Free radicals; Hemochromatosis; Lipid peroxidation; Oxidative stress

Indexed keywords

6 HYDROXYMELATONIN; FERRIC ION; FERROUS ION; HYDROXYL RADICAL;

ADSORPTION; ANIMAL TISSUE; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; DRUG EFFECT; FENTON REACTION; LIPID PEROXIDATION; LIVER HOMOGENATE; MALE; NONHUMAN; OXIDATION REDUCTION POTENTIAL; RAT;

ANIMALS; ELECTROCHEMISTRY; ELECTRODES; FERRIC COMPOUNDS; FERROUS COMPOUNDS; IRON; LIPID PEROXIDATION; LIVER; MALE; MELATONIN; OXIDATION-REDUCTION; RATS; RATS, WISTAR; SOLUTIONS;

EID: 0037422967     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02405-0     Document Type: Article

References (17)

1. Reiter R.J., Tan D.X., Qi W.B., Manchester L.C., Karbownik M., Calvo J.R. Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo. Biolog Signals Recpt. 9:2000;160-171.
2. Tan D.X., Manchester L.C., Reiter R.J., Plummer B.F., Hardies L.J., Weintraub S.T., Vijayalaxmi, Shephard A.M. A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation. Biochem. Biophys. Res. Commun. 253:1998;614-620.
3. Tan D.X., Manchester L.C., Burkhardt S., Sainz R.M., Mayo J.C., Kohen R., Shohami E., Huo Y.S., Hardeland R., Reiter R.J. N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J. 15:2001;2294-2296.
4. Matuszak K., Reszka K.J., Chignell C.F. Reaction of melatonin and related indoles with hydroxyl radicals: EPR and Spin trapping investigation. Free Radical. Biol. Med. 23:1997;367-372.
5. Pierrefiche G., Topall G., Courboin G., Henriet I., Laborit H. Antioxidant activity of melatonin in mice. Res. Commun. Chem. Pathol. Pharmacol. 80:1993;211-223.
6. Tse S.Y., Mak I.T., Dickens B.F. Antioxidative properties of harmane and β-carbolines alkaloids. Biochem. Pharmacol. 42:1991;459-464.
7. National Research Council. Iron. Baltimore: University Park Press; 1979
8. Lauffer R. Iron and human diseases. Boca Raton: CRC Press; 1992.
9. Braughler J.M., Hall E.D. Central nervous system trauma and stroke. Free Radical Biol. Med. 6:1989;289-301.
10. Fahn S., Cohen G. The oxidant stress hypothesis in Parkinson's Disease. Ann. Neurol. 32:1992;804-812.
11. 2. J. Biol. Chem. 262:1987;1098-1104.
12. Gutteridge J.M.C., Richmond R., Halliwell B. Inhibition of the iron catalysed formation of hydroxyl radicals from superoxide and lipid peroxidation by desferrioxamine. Biochem. J. 184:1979;469-472.
13. Braughler J.M., Chase R.L., Pregenzer J.F. Oxidation of ferrous ion during peroxidation of various lipid substrates. Biochem. Biophys. Acta. 921:1987;457-464.
14. Sreejayan N., Rao M.N.A. Curcumin inhibits iron-dependent lipid peroxidation. Int. J. Pharmac. 100:1993;93-97.
15. Anoopkumar-Dukie S., Walker R.B., Daya S. A sensitive and reliable method for the detection of lipid peroxidation in biological tissues. J. Pharm. Pharmacol. 53:2001;263-266.
16. Zar J.H. Biostatistical analysis. Englewood Cliffs, NJ: Prentice Hall, 1974.
17. Limson J., Nyokong T., Daya S. The interaction of melatonin and its precursors with aluminium, cadmiun, copper, iron, lead and zinc: an adsorptive voltammetric study. J. Pineal Res. 1:1998;15-21.